AAAA Therapy: Using information from research on populations to help with clinical decisions about treatments Flashcards

1
Q

4 stages of AAAA framework

A
  • Assess
  • Access
  • Appraise
  • Act
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the aim of “assess”

A

Define the clinical question, study design and clinical components

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What format are the clinical components in “assess” arranged in?

A
  • PICO
    > Population
    > Intervention
    > Comparator
    > Outcomes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the aim of “access”

A

Finding studies (that are clinically relevant to the question)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

2 stages of appraisal

A
  • Quality of the conduct of the study (risk of bias)
  • Interpretation of results
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Basic questions of assessing quality of the conduct of the study in appraisal

A
  • First
    > Does the study address a research question relevant to the clinical problem?
    > Did researchers use the study design most likely to provide a valid answer?
  • Then
    > Was the study done well/is it trustworthy?
    > If done well, what were the results?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Comparator vs control group

A
  • Control = placebo or standard, pre-existing treatment
  • Comparator = another treatment being assessed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why have a control/comparator group?

A
  • Both increase sample size
  • Comparator gives patients a choice about which treatment
  • Control allows evaluation of whether patients would have gotten better anyway with no treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Additional features of an RCT to mitigate against bias

A
  • Allocation concealment
  • Blinding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is allocation concealment

A

The allocation sequence is concealed from participants and those recruiting them so it cannot influence who actually receives treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which type of bias does allocation concealment prevent?

A

Selection bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is allocation concealment carried out

A
  • Computer generated random sequence is performed distant to where trial is being conducted
  • Treatment allocation should be concealed until administration (eg. sealed envelopes) (where possible)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which types of bias does blinding remove?

A
  • Measurement bias
  • Performance bias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does blinding remove measurement bias?

A
  • Stops patients’ perception of pain, etc. being influenced by preconceived ideas about effectiveness of a treatment
  • Stops patients giving socially desirable responses if they know they are in the intervention arm
  • Stops preconceived ideas about how effective a treatment is influencing how observers measure subjective outcomes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does blinding remove performance bias?

A
  • Stops HCPs delivering treatment differently to different groups because of preconceived ideas about effectiveness of a treatment
  • Stops participants behaving differently because they are disappointed in which group they were allocated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

At which levels can blinding take place?

A
  • Participants
  • Clinicians delivering treatment
  • Researchers measuring outcomes
  • Statisticians undertaking analysis
17
Q

Single vs double vs triple blind

A
  • Single = blinding takes place on 1 level
  • Double = blinding takes place on any 2 levels
  • Triple = blinding takes place on any 3 levels
18
Q

What is considered when interpreting results?

A
  • Direction of effect
  • Size of effect estimate
  • Precision of effect estimate
  • Statistical significance of effect estimate
  • Clinical significance of effect
19
Q

How is effectiveness measured?

A
  • Risk of specific outcome in each group calculated then…
    > Risk difference calculated
    > Relative risk calculated
    > Number needed to treat calculated
20
Q

How is risk of specific outcome in each group calculated?

A

Number with specific outcome / Total number in group

21
Q

How is risk difference calculated?

A

Risk of specific outcome in treatment group - Risk of specific outcome in comparator group

22
Q

How is relative risk calculated?

A

Risk of specific outcome in treatment group / Risk of specific outcome in comparator group

23
Q

How is number needed to treat calculated?

A

1 / Risk difference

24
Q

What is number needed to treat?

A

Number of people needed to treat for 1 more person to have outcome

25
Q

What different relative risk values mean

A
  • RR = 1 –> no difference between groups
  • RR > 1 –> more outcomes in treatment group vs comparator group
  • RR < 1 –> less outcomes in treatment group vs comparator group
26
Q

What different risk difference values mean

A
  • RD = 0 –> no difference between groups
  • RD > 0 –> more risk of outcome in treatment vs comparator group
  • RD < 0 –> less risk of outcome in treatment vs comparator group
27
Q

What is used to measure precision of results?

A

Confidence intervals

28
Q

What is a confidence interval?

A

Estimation of the range within the true size of effect lies (eg. 95% CI for RD of +22 could be +18 to +26, meaning 95/100 repetitions of the trial would give RD value between +18 and +26)

29
Q

What is the aim of “act”

A

Decide whether your practice should change due to the results of the evidence